Skip to main content
Equibles

SPHERA FUNDS MANAGEMENT LTD.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1496201 TEL AVIV, L3
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$50,822,778
+$16,577,091 QoQ
Shares Held
1,500,082
+31.9% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
7.42%
of 13F equity value
Holder Rank
#68
of 675 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Jun 30, 2024
CallValue
$53,119,625
CallShares
3,268,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $61,616,864 across 4 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (82.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
This page 		1,500,082 $50,822,778
2 BIOA
BioAge Labs, Inc.
 213,671 $5,237,076
3 BCRX
Biocryst Pharmaceuticals Inc
 422,051 $4,220,510
4 ORGO
Organogenesis Holdings Inc.
 550,000 $1,336,500

All Filings in TEVA

Export CSV
37 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,822,778 1,500,082
2026-03-31 $34,245,687 1,136,975
2025-12-31 $35,065,215 1,123,525
2025-09-30 $30,441,905 1,507,025
2025-06-30 $27,167,792 1,620,990
2025-03-31 $24,164,421 1,572,181
2024-12-31 $34,584,749 1,569,181
2024-09-30 $38,386,492 2,130,216
2024-06-30 $53,119,625 3,268,900
2024-06-30 $12,828,010 789,416
2024-03-31 $44,202,397 3,132,700
2024-03-31 $26,663,667 1,889,700
2023-12-31 $13,404,960 1,284,000
2023-12-31 $25,777,404 2,469,100
2023-09-30 $6,120,000 600,000
2023-09-30 $51,140,760 5,013,800
2023-06-30 $61,329,591 8,144,700
2023-06-30 $7,906,500 1,050,000
2023-03-31 $18,049,575 2,039,500
2023-03-31 $18,027,450 2,037,000
2022-09-30 $6,265,112 776,346
2022-06-30 $8,632,042 1,147,878
2022-06-30 $25,429,632 3,381,600
2022-03-31 $17,747,100 1,890,000
2022-03-31 $1,971,900 210,000
2022-03-31 $7,820,724 832,878
2021-12-31 $6,671,344 832,877
2021-09-30 $10,227,000 1,050,000
2021-09-30 $8,112,231 832,878
2021-06-30 $18,909,000 1,910,000
2021-06-30 $8,245,492 832,878
2021-03-31 $10,256,752 888,800
2021-03-31 $9,611,412 832,878
2020-12-31 $8,037,272 832,878
2020-09-30 $14,261,730 1,582,878
2020-06-30 $7,186,885 582,878
2020-03-31 $3,203,282 356,713